Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
26/07/202413:27Alliance NewsAlliance NewsIN BRIEF: Astra pushes to get Imfinzi approved for lung cancer in USLSE:AZNAstrazeneca Plc
26/07/202413:27Alliance NewsAlliance NewsIN BRIEF: Astra pushes to get Imfinzi approved for lung cancer in USLSE:AZNAstrazeneca Plc
26/07/202407:00RNS Regulatory NewsAstraZeneca PLC ODAC reviewed Imfinzi in resectable lung cancerLSE:AZNAstrazeneca Plc
25/07/202409:37Alliance NewsAlliance NewsTOP NEWS: AstraZeneca shares fall despite improved full-year outlookLSE:AZNAstrazeneca Plc
25/07/202409:37Alliance NewsAlliance NewsTOP NEWS: AstraZeneca shares fall despite improved full-year outlookLSE:AZNAstrazeneca Plc
25/07/202407:00RNS Regulatory NewsAstraZeneca PLC Half-year ReportLSE:AZNAstrazeneca Plc
15/07/202407:00RNS Regulatory NewsAstraZeneca PLC Acquisition of Amolyt Pharma completedLSE:AZNAstrazeneca Plc
05/07/202408:36Alliance NewsAlliance NewsTOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer formLSE:AZNAstrazeneca Plc
05/07/202408:36Alliance NewsAlliance NewsTOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer formLSE:AZNAstrazeneca Plc
03/07/202409:57Alliance NewsAlliance NewsAptamer shares jump as inks agreement with AstraZenecaLSE:AZNAstrazeneca Plc
03/07/202409:57Alliance NewsAlliance NewsAptamer shares jump as inks agreement with AstraZenecaLSE:AZNAstrazeneca Plc
01/07/202415:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
01/07/202409:13Alliance NewsAlliance NewsTOP NEWS: AstraZeneca cancer and Covid drugs recommended for approvalLSE:AZNAstrazeneca Plc
01/07/202409:13Alliance NewsAlliance NewsTOP NEWS: AstraZeneca cancer and Covid drugs recommended for approvalLSE:AZNAstrazeneca Plc
01/07/202407:00RNS Regulatory NewsAstraZeneca PLC Lynparza & Imfinzi positive CHMP in endometrialLSE:AZNAstrazeneca Plc
26/06/202408:40Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in ChinaLSE:AZNAstrazeneca Plc
26/06/202408:40Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in ChinaLSE:AZNAstrazeneca Plc
25/06/202409:05Alliance NewsAlliance NewsTOP NEWS: AstraZeneca details mixed findings from cancer drug trialsLSE:AZNAstrazeneca Plc
25/06/202409:05Alliance NewsAlliance NewsTOP NEWS: AstraZeneca details mixed findings from cancer drug trialsLSE:AZNAstrazeneca Plc
25/06/202407:05RNS Regulatory NewsAstraZeneca PLC Update on Imfinzi ADJUVANT BR.31 trialLSE:AZNAstrazeneca Plc
25/06/202407:00RNS Regulatory NewsAstraZeneca PLC Imfinzi improved EFS and OS in bladder cancerLSE:AZNAstrazeneca Plc
20/06/202410:56Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer formLSE:AZNAstrazeneca Plc
20/06/202410:56Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer formLSE:AZNAstrazeneca Plc
18/06/202409:33Alliance NewsAlliance NewsTOP NEWS: AstraZeneca disappointed by breast cancer drug trial resultsLSE:AZNAstrazeneca Plc
18/06/202409:33Alliance NewsAlliance NewsTOP NEWS: AstraZeneca disappointed by breast cancer drug trial resultsLSE:AZNAstrazeneca Plc
18/06/202407:00RNS Regulatory NewsAstraZeneca PLC Update on CAPItello-290 Phase III trialLSE:AZNAstrazeneca Plc
17/06/202409:09Alliance NewsAlliance NewsTOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in USLSE:AZNAstrazeneca Plc
17/06/202409:09Alliance NewsAlliance NewsTOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in USLSE:AZNAstrazeneca Plc
17/06/202407:23Alliance NewsAlliance NewsIN BRIEF: AstraZeneca gets positive cancer test results for CalquenceLSE:AZNAstrazeneca Plc
17/06/202407:23Alliance NewsAlliance NewsIN BRIEF: AstraZeneca gets positive cancer test results for CalquenceLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN